Title: Correlation of Urine Cytology for Urothelial Carcinoma as per Paris System with Histopathology

Authors: Dr Aditya Jamwal, Dr Sudarshan Kumar Sharma, Dr Neelam Sharma, Dr Pamposh Raina, Dr Anjali Mahajan

 DOI: https://dx.doi.org/10.18535/jmscr/v8i5.13

Abstract

 

Objectives: This study aims to evaluate the diagnostic accuracy of urine cytology for urothelial carcinomas as per the Paris System and its histopathological correlation.

Methods: A cross-sectional study was conducted over 1 year (July 2018 – June 2019). The study population comprised patients presenting with haematuria/dysuria and had radiological findings suggestive of bladder tumor. Preoperative, early morning, midstream, voided urine samples were collected and processed for three consecutive days. The cytospin smears were stained with Papanicolaou stain and reported as per the Paris system. These results were then correlated with gold standard test i.e. Histopathology of TURBT as per WHO classification 2016(4). Relevant statistical tests were utilized for data analysis. 

Results: 40 cases were studied. According to the reporting criteria of the Paris System, 62.5% cases were positive for malignancy and 37.5% cases were negative for malignancy.  On histopathology, 82.5% cases were positive for urothelial carcinoma and 17.5% cases were negative for urothelial carcinoma. The sensitivity of urine cytology was calculated to be 75%, specificity of urine cytology was 87.5% and the positive predictive value was 96%.       

Conclusion: Urine Cytology as reported by the Paris System will lead to uniform and unequivocal reporting of urothelial carcinoma.

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer statistics. CA Cancer J Clin.2011;61: 69-90.
  2. Murphy WM. Current Status of Urinary Cytology in the evaluation of Bladder Neoplasms. Human Pathology 1990, sept; 21(9): 886-896.
  3. Guliz A. Barkan, Eva M. Wojcik, Ritu Nayar: The paris system for reporting urinary cytology: A quest to develop a standardized terminology 2016, June 18,60:185-197.
  4. Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumors of the Urinary System and Male Genital Organs. 4th France: International agency for research on Cancer (IARC); 2016
  5. Chritopher L. Owens, Christopher J. VandenBussche, Frances H. Burroughs et al. A review of reporting systems and terminology for Urine Cytology. Cancer Cytopathol. 2013;121:9-14.
  6. Soumitra Das, Anandi Roy Chowdhary, Supriya Basu. Evaluation of Urine Cytology in Urothelial Carcinoma with respect to The Paris System for Reporting Urine Cytology. Journal of Medical science and clinical research. 2017 November;461-470.
  7. Sharada Rai, Bhagat S. Lali et al: Evaluation of The Paris System in Diagnosis of Urothelial Carcinomas. J. Cytol 2019;36:160-173.
  8. Somaye Zare, MD, Leili Mirsadraei et al: A single institutional experience with The Paris System for reporting Urinary Cytology. Am J Clin Pathol 2018;150:162-167.
  9. Muhannad Hassan, MD, Sharaddha Solanki et al: Impact of Implementing the Paris System for reporting urine cytology in the performance of Urine cytology. Am J Clin Pathol 2016;146:384-390.

Corresponding Author

Dr Sudarshan Kumar Sharma

Professor and Head of Department, Department of Pathology